Its ability to modulate autophagy and mitigate mitochondrial ROS generation, particularly via the SIRT1- and SIRT3-mediated pathways, highlights its potential utility in disrupting tumor growth [102]. This evidence concerns the gene SIRT1 and neoplasm.